| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.38B | 20.73B | 16.71B | 14.58B | 12.44B | 10.39B |
| Gross Profit | 9.21B | 10.73B | 8.60B | 7.47B | 6.70B | 5.61B |
| EBITDA | 3.43B | 4.07B | 3.29B | 2.81B | 2.10B | 1.47B |
| Net Income | 966.64M | 1.12B | 917.23M | 646.96M | 432.65M | 128.87M |
Balance Sheet | ||||||
| Total Assets | 15.19B | 18.63B | 15.56B | 14.34B | 13.38B | 12.18B |
| Cash, Cash Equivalents and Short-Term Investments | 4.06B | 5.22B | 4.70B | 5.33B | 4.77B | 5.10B |
| Total Debt | 5.95B | 6.64B | 5.91B | 6.10B | 5.64B | 6.23B |
| Total Liabilities | 10.18B | 12.73B | 10.69B | 10.35B | 9.97B | 9.09B |
| Stockholders Equity | 5.01B | 5.90B | 4.87B | 3.99B | 3.40B | 3.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 428.49M | -102.51M | 264.62M | 497.52M | -133.36M |
| Operating Cash Flow | 0.00 | 4.04B | 2.51B | 2.54B | 2.55B | 1.59B |
| Investing Cash Flow | 0.00 | -4.28B | -2.73B | -2.44B | -2.18B | -1.93B |
| Financing Cash Flow | 0.00 | 559.75M | -305.46M | 347.74M | -698.28M | 528.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥250.08B | 19.80 | ― | 2.18% | 8.08% | -27.93% | |
72 Outperform | ¥9.41B | 6.16 | ― | 1.86% | 24.09% | 22.23% | |
71 Outperform | ¥54.00B | 8.73 | ― | 3.94% | 2.40% | 15.35% | |
66 Neutral | ¥8.01B | 8.93 | ― | 3.96% | 6.05% | -67.41% | |
63 Neutral | ¥1.47T | 27.67 | 5.92% | 1.93% | 1.37% | -38.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥221.11B | 20.90 | 15.93% | 0.72% | 18.35% | 15.11% |